Clive Glover

Clive Glover is an accomplished leader in the life sciences industry, currently serving as Vice President/General Manager at Cytiva, overseeing both Pall Medical and Viral Vectors. With extensive experience at Pall Corporation from 2017 to 2022 and GE Healthcare from 2012 to 2017, Glover has a proven track record in product management, strategy, and marketing within the cell and gene therapy sectors. Glover's career began at STEMCELL Technologies, where leadership in product management involved launching successful product lines and achieving significant revenue growth. Glover's academic credentials include a PhD in Genetics and an MSc in Applied Mathematics from The University of British Columbia, along with a BSc from McGill University.